TEVA Sucralfate is a gastroduodenal cytoprotective agent supplied as 1 g oral tablets. Labeled for anti-ulcer and antacid use, it is intended for administration under professional direction. Each tablet contains 1 g of sucralfate with nonmedicinal excipients for tablet stability and integrity. Available in 100- and 500-tablet bottles (DIN 02045702) to suit clinic and pharmacy inventory needs. Prescription required in Canada.